GoldenGolden
Advanced Search
Second Genome

Second Genome

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

Second Genome is a company that has the mission to redefine disease in terms of microbiome medicine. It uses proprietary microbiome drug discovery and development platform to find effective peptides, proteins and small molecule therapeutics.

Timeline

Funding rounds

SBA Awards

Patents

Products

People

Name
Role
LinkedIn

Adam Altrichter

Employee

Ali A. Faruqi

Employee

Amit Bansal

Investor

Andrew Han

Employee

Anh Vu

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Second Genome
June 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform sg-4-sight and AI workflows to discover and develop precision...
Second Genome
June 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Second Genome, a tech-enabled biotechnology company that extracts microbial genetic insights to make transformational precision therapies and...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.